The pharmaceutical industry is rapidly evolving, with substantial demand for high-efficacy Active Pharmaceutical Ingredients (APIs). Dulaglutide, a diabetes drug, stands as example of this trend. To fulfill this demand, US-based manufacturing services are gaining traction. These providers offer a